Table of Contents
CHAPTER ONE: INTRODUCTION
- STUDY GOALS AND OBJECTIVES
- REASONS FOR DOING THE STUDY
- INTENDED AUDIENCE
- SCOPE OF REPORT
- METHODOLOGY
- INFORMATION SOURCES
- RELATED BCC REPORTS
- ANALYST CREDENTIALS
- BCC RESEARCH ONLINE SERVICES
- DISCLAIMER
CHAPTER TWO: SUMMARY
- SUMMARY TABLE GLOBAL VALUE OF BIOLOGIC IMAGING REAGENTS, BY TYPE, THROUGH
2013 ($ MILLIONS)
- SUMMARY FIGURE GLOBAL VALUE OF BIOLOGIC IMAGING REAGENTS, BY TYPE,
2006-2013 ($ MILLIONS)
- SUMMARY (CONTINUED)
CHAPTER THREE: OVERVIEW
- INTRODUCTION
- BIOLOGIC IMAGING TECHNOLOGIES COVERED IN THIS REPORT
- TABLE 1 SCOPE OF THIS REPORT
- MARKET POTENTIAL OF BIOLOGIC REAGENTS PRODUCTS
- TABLE 2 GLOBAL VALUE OF BIOLOGIC IMAGING REAGENTS, BY TECHNOLOGY,
THROUGH 2013 ($ MILLIONS)
- TABLE 3 GLOBAL VALUE OF BIOLOGIC IMAGING REAGENTS, BY END USER MARKET,
THROUGH 2013 ($ MILLIONS)
- FORCES DRIVING BIOLOGIC IMAGING REAGENTS INDUSTRY GROWTH
- TABLE 4 BIOLOGIC IMAGING REAGENTS GROWTH DRIVING FORCES
- FORCES DRIVING BIOLOGIC ..... (CONTINUED)
- LIFE CYCLE STATUS OF BIOLOGIC IMAGING REAGENTS TECHNOLOGIES
- TABLE 5 LIFE CYCLE STAGE OF BIOLOGIC IMAGING REAGENTS
- THE BIOLOGIC IMAGING REAGENTS INDUSTRY
- TABLE 6 BIOLOGIC IMAGING REAGENTS KEY COMPETITORS
- THE BIOLOGIC IMAGING REAGENTS ..... (CONTINUED)
CHAPTER FOUR: BIOLOGIC IMAGING TECHNOLOGIES
- IMAGING REAGENT TYPES
- TABLE 7 KEY BIOLOGIC IMAGING REAGENT TYPES
- IN-VIVO IMAGING MODALITIES
- TABLE 8 IN-VIVO IMAGING MODALITIES
- TABLE 9 COMPARISON OF IN-VIVO IMAGING MODALITIES
- IN-VIVO IMAGING MODALITIES (CONTINUED)
- MOLECULAR IMAGING
- IN-VITRO IMAGING/DETECTION
- TABLE 10 APPLICATIONS OF IN-VITRO BIOLOGIC IMAGING
- TRENDS IN IN-VIVO IMAGING
- TABLE 11 KEY TRENDS FOR IN-VIVO IMAGING
- TRENDS IN IN-VIVO IMAGING (CONTINUED)
- BIOLOGIC IMAGING REAGENTS TECHNOLOGIES
- NANOPARTICLES
- TABLE 12 NANOPARTICLES IN IMAGING APPLICATIONS
- Nanoparticles (Continued)
- TABLE 13 COMPARISON OF ANTIBODY CONJUGATE NANOPARTICLES
- FLUORESCENT DYES AND PROBES
- TABLE 14 FLUORESCENT DYES AND PROBES
- Fluorescent Dyes and Probes (Continued)
- TABLE 15 ADVANTAGES OF FLUORESCENCE VERSUS TRADITIONAL METHODS
- TABLE 16 FLUORESCENT DYE PERFORMANCE CRITERIA
- FLUORESCENT PROTEINS
- TABLE 17 TYPES OF FLUORESCENT PROTEINS
- Fluorescent Proteins (Continued)
- Genetically Engineering Fluorescent Proteins
- TABLE 18 PHOTOACTIVABLE AND PHOTOCONVERTIBLE FLUORESCENT PROTEIN TYPES
- Engineered Fluorescent Cell Lines
- Emerging Fluorescent Protein Applications
- TABLE 19 EMERGING APPLICATIONS OF FLUORESCENT PROTEINS
- Comparison of Fluorescent Proteins with Fluorescent Dyes
- TABLE 20 FLUORESCENT PROTEINS VERSUS DYES
- Technology Challenges
- TABLE 21 TECHNOLOGY CHALLENGES FOR FLUORESCENT PROTEINS
- SUPERMOLECULES
- TABLE 22 CLASSIFICATION OF IMAGING SUPERMOLECULES
- SUPERMOLECULES (Continued)
- FIGURE 1 MOLECULAR ENGINEERING OF DENDRIMER IMAGING SUPERMOLECULES
- QUANTUM DOTS
- TABLE 23 COMPARISON OF QUANTUM DOTS, FLUORESCENT DYES AND FLUORESCENT
PROTEINS
- FIGURE 2 QUANTUM DOT SPECTRA
- FIGURE 3 FLUORESCENT DYE SPECTRA
- Quantum Dots (Continued)
- TABLE 24 BIOLOGIC IMAGING APPLICATIONS OF QUANTUM DOTS
- RADIOPHARMACEUTICALS
- CONTRAST REAGENTS
- Contrast Reagents (Continued)
- Contrast Reagents (Continued)
- EMERGING CLASSES OF IMAGING REAGENTS
- COMPONENTS OF ADVANCED IMAGING REAGENT TECHNOLOGY
- FIGURE 4 THREE COMPONENTS OF ADVANCED IMAGING
- REAGENT TECHNOLOGY
- ADVANCED IMAGING REAGENT FUNCTIONS
- TABLE 25 EMERGING ADVANCED BIOLOGIC IMAGING REAGENT FUNCTIONS
- Dual Modality Reagents
- Multifunctional Reagents
- Multifunctional Reagents (Continued)
- Multiplexed Reagents
- BIOLOGIC IMAGING REAGENTS MANUFACTURING COSTS
- FIGURE 5 MANUFACTURING COSTS OF IMAGING REAGENT CLASSES
- BIOLOGIC IMAGING REAGENTS ..... (CONTINUED)
- COMPARISON OF IMAGING REAGENT TECHNOLOGY PLATFORMS
- TABLE 26 LIFE CYCLE OF BIOLOGIC IMAGING REAGENT TECHNOLOGIES
- TABLE 27 TECHNOLOGY STATUS OF BIOLOGIC IMAGING REAGENT PLATFORMS
- TABLE 28 TECHNOLOGY CHALLENGES FOR IN-VIVO IMAGING REAGENTS
- COMPARISON OF IMAGING ..... (CONTINUED)
CHAPTER 5: BIOLOGIC IMAGING REAGENTS APPLICATIONS
- OVERVIEW
- TABLE 29 BIOLOGIC IMAGING REAGENTS APPLICATIONS
- TABLE 30 SIGNIFICANCE OF BIOLOGIC IMAGING REAGENTS TO LIFE SCIENCES AND
MEDICAL INDUSTRIES
- TABLE 31 USE OF BIOLOGIC IMAGING REAGENTS BY MARKET SEGMENT
- TABLE 31 (CONTINUED)
- TABLE 32 APPLICATIONS WITHIN MARKET SEGMENTS
- RESEARCH AND DEVELOPMENT
- TABLE 33 R&D TOOLS
- TABLE 34 EMERGING APPLICATIONS FOR BIOLOGIC IMAGING REAGENTS IN R&D TOOLS
- DRUG DISCOVERY AND DEVELOPMENT
- TABLE 35 DRUG DISCOVERY & DEVELOPMENT
- INFLUENCE OF IMAGING TECHNOLOGY ON DRUG DEVELOPMENT
- ATTRITION RATE OF LEAD COMPOUNDS
- FIGURE 6 ATTRITION RATE OF DRUG CANDIDATES DURING DRUG DEVELOPMENT
- FLUORESCENT PROTEIN APPLICATIONS IN DRUG DISCOVERY
- IN-VIVO SMALL ANIMAL IMAGING APPLICATIONS
- TABLE 36 COMPARISON OF SMALL ANIMAL IMAGING MODALITIES
- TABLE 37 OUTSTANDING MARKET NEEDS FOR SMALL ANIMAL IMAGING
- MICRODOSING
- Biomarkers for Microdosing
- TABLE 38 BIOMARKERS FOR MICRODOSING
- Regulatory Requirements for Microdosing
- Imaging Modalities for Microdosing
- TABLE 39 MICRODOSING IMAGING MODALITIES
- Status of Microdosing
- DIAGNOSTICS
- INTRODUCTION
- TABLE 40 DIAGNOSTICS IMAGING REAGENTS APPLICATIONS
- TABLE 40 (CONTINUED)
- DIAGNOSTIC APPLICATIONS OF IMAGING REAGENTS
- TABLE 41 DIAGNOSTIC APPLICATIONS OF SELECTED IMAGING REAGENTS
- Fluorescent Dyes, Probes and Tags
- Nanoparticles
- Supermolecules
- Imaging Radiopharmaceuticals
- Contrast Reagents
- MOLECULAR IMAGING
- Introduction
- TABLE 42 CLINICAL APPLICATIONS FOR IN VIVO MOLECULAR IMAGING
- Optical Molecular Imaging Reagents Status
- TABLE 43 FLUORESCENCE IMAGING REAGENTS PIPELINE STATUS
- PET/SPECT Molecular Imaging Reagents Status
- TABLE 44 PET/SPECT IMAGING REAGENTS PIPELINE STATUS
- TABLE 44 (CONTINUED)
- PET/SPECT .....(Continued)
- Biological Processes Associated with Molecular PET Imaging Reagents
- TABLE 45 PET IMAGING REAGENT APPLICATIONS
- Biological Processes ..... (Continued)
- CASE STUDY: ALZHEIMER' S DISEASE IMAGING REAGENT OPPORTUNITIES
- FIGURE 7 ALZHEIMER' S DISEASE' S PATHOLOGY PROGRESSION
- MR IMAGING REAGENTS
- TABLE 46 EXISTING AND EMERGING MRI IMAGING REAGENTS STATUS
- TABLE 46 (CONTINUED)
- ULTRASOUND IMAGING REAGENTS
- NANOPARTICLES IN DIAGNOSTICS
- TABLE 47 NANOPARTICLE IN-VIVO DIAGNOSTICS PIPELINE
- TABLE 48 NANOSPHERE IN-VITRO DIAGNOSTICS REAGENTS PIPELINE
- HYBRID DIAGNOSTIC/THERAPEUTIC APPLICATIONS
- TABLE 49 HYBRID IMAGING/THERAPEUTIC APPLICATIONS
- Hybrid Diagnostic/..... (Continued)
CHAPTER SIX: BIOLOGIC IMAGING REAGENTS INDUSTRY STRUCTURE
- MEDICAL IMAGING INSTRUMENT INDUSTRY
- TABLE 50 COMPETITIVE FOCUS OF MAJOR MEDICAL IMAGING COMPANIES
- INNOVATION WITHIN THE IMAGING REAGENT INDUSTRY
- ROLE OF CORE IMAGING FACILITIES
- ROLE OF STRATEGIC ALLIANCES
- TABLE 51 RECENT IMAGING REAGENT STRATEGIC ALLIANCES
- TABLE 51 (CONTINUED)
- TABLE 51 (CONTINUED)
- Role of Strategic Alliances (Continued)
- TABLE 52 BIOLOGIC IMAGING REAGENTS INDUSTRY ACQUISITIONS, 2005-2008
- TABLE 52 (CONTINUED)
- TABLE 52 (CONTINUED)
- TABLE 52 (CONTINUED)
- 2005
- 2006
- 2006 (Continued)
- 2007
- 2008
- SPECIALIZED INDUSTRY SECTORS
- FLUORESCENT DYES AND PROBES
- TABLE 53 FLUORESCENT DYES AND PROBES KEY COMPETITORS
- QUANTUM DOTS
- TABLE 54 QUANTUM DOTS KEY COMPETITORS
- TABLE 54 (CONTINUED)
- CONTRAST REAGENTS
- TABLE 55 CONTRAST REAGENTS KEY COMPETITORS
- RADIOPHARMACEUTICALS
- TABLE 56 RADIOPHARMACEUTICALS BIOTECHNOLOGY COMPANIES
- Radioactive Isotope Supply Industry
- SMALL ANIMAL IN-VIVO IMAGING
- TABLE 57 SMALL ANIMAL IN-VIVO FUNCTIONAL IMAGING COMPETITORS
- CARDIAC IMAGING
- TABLE 58 CARDIAC IMAGING REAGENT COMPETITIVE SPACE
- FLUORESCENT PROTEINS
- TABLE 59 FLUORESCENT PROTEIN PRODUCERS
- ANTIBODY BIOTECHNOLOGY COMPANIES
- TABLE 60 ANTIBODY BIOTECHNOLOGY COMPANIES WHO HAVE INTEREST IN IMAGING
REAGENTS
CHAPTER SEVEN: BIOLOGIC IMAGING REAGENTS MARKETS
- GROWTH DRIVING FORCES
- TABLE 61 BIOLOGIC IMAGING REAGENTS GROWTH DRIVING FORCES
- GROWTH DRIVING FORCES (CONTINUED)
- INSTRUMENTS MARKETS
- TABLE 62 GLOBAL VALUE OF INSTRUMENTS AND ASSAYS UTILIZING BIOLOGIC
IMAGING REAGENTS, THROUGH 2013 ($ MILLIONS)
- TABLE 62 (CONTINUED)
- BIOLOGIC IMAGING REAGENTS MARKETS
- MARKET OVERVIEW
- TABLE 63 GLOBAL VALUE OF BIOLOGIC IMAGING REAGENTS, BY TECHNOLOGY,
THROUGH 2013 ($ MILLIONS)
- TABLE 64 GLOBAL VALUE OF BIOLOGIC IMAGING REAGENTS MARKET, BY END USE,
THROUGH 2013 ($ MILLIONS)
- TABLE 65 GLOBAL VALUE OF BIOLOGIC REAGENTS MARKET, BY FUNCTION, THROUGH
2013 ($ MILLIONS)
- TABLE 66 GLOBAL VALUE OF BIOLOGIC IMAGING REAGENTS, BY END USER MARKET,
THROUGH 2013 ($ MILLIONS)
- TABLE 67 GLOBAL VALUE OF BIOLOGIC REAGENTS MARKET, BY MODALITY, THROUGH
2013 ($ MILLIONS)
- FLUORESCENT PROTEINS
- TABLE 68 GLOBAL VALUE OF FLUORESCENT PROTEIN REAGENTS, BY TYPE, THROUGH
2013 ($ MILLIONS)
- NANOPARTICLES
- TABLE 69 GLOBAL VALUE OF IMAGING NANOPARTICLES BY TECHNOLOGY THROUGH
2013 ($ MILLIONS)
- CONTRAST REAGENTS
- TABLE 70 GLOBAL VALUE OF CONTRAST AGENTS MARKET, BY MODALITY, THROUGH
2013 ($ MILLIONS)
- TABLE 71 GLOBAL VALUE OF MRI REAGENTS MARKET, BY TYPE, THROUGH 2013 ($
MILLIONS)
- TABLE 72 GLOBAL VALUE OF MRI GD CHELATE REAGENTS, BY PRODUCT, THROUGH
2013 ($ MILLIONS)
- TABLE 72 (CONTINUED)
- Contrast Reagents (Continued)
- Nephrogenic Systemic Fibrosis Impact on Gd-based Contrast Agents
- TABLE 73 GLOBAL VALUE OF MRI NON-GD CHELATE REAGENTS, BY PRODUCT,
THROUGH 2013 ($ MILLIONS)
- TABLE 74 GLOBAL SALES OF MRI CONTRAST REAGENTS, BY PROCEDURE, THROUGH
2013 ($ MILLIONS)
- TABLE 75 GLOBAL VALUE OF ULTRASOUND REAGENTS MARKET, BY TYPE, THROUGH
2013 ($ MILLIONS)
- TABLE 76 GLOBAL VALUE OF X-RAY/CT REAGENTS MARKET, BY TYPE, THROUGH 2013
($ MILLIONS)
- RADIOPHARMACEUTICALS
- TABLE 77 GLOBAL VALUE OF RADIOPHARMACEUTICALS IMAGING REAGENTS MARKET,
BY INDICATION, THROUGH 2013 ($ MILLIONS)
- TABLE 78 GLOBAL VALUE OF ONCOLOGY RADIOPHARMACEUTICALS IMAGING REAGENTS
MARKET, BY INDICATION, THROUGH 2013 ($ MILLIONS)
- TABLE 79 GLOBAL VALUE OF ONCOLOGY RADIOPHARMACEUTICALS IMAGING REAGENTS
MARKET, BY PRODUCT, THROUGH 2013 ($ MILLIONS)
- TABLE 80 GLOBAL VALUE OF FDG RADIOPHARMACEUTICAL REAGENTS, BY DISEASE
CLASS, THROUGH 2013 ($ MILLIONS)
- OPTICAL IMAGING REAGENTS
- TABLE 81 GLOBAL VALUE OF OPTICAL FLUORESCENT IMAGING REAGENTS MARKET, BY
APPLICATION, THROUGH 2013 ($ MILLIONS)
- TABLE 82 GLOBAL VALUE OF IN-VITRO RESEARCH AND DRUG DISCOVERY AND
DEVELOPMENT OPTICAL FLUORESCENT IMAGING REAGENTS MARKET, BY ASSAY, THROUGH
2013 ($ MILLIONS)
- TABLE 83 GLOBAL VALUE OF GENOMICS IN-VITRO OPTICAL FLUORESCENT IMAGING
REAGENTS MARKET, BY ASSAY TYPE, THROUGH 2013 ($ MILLIONS)
- TABLE 84 GLOBAL VALUE OF PROTEOMICS IN-VITRO OPTICAL FLUORESCENT IMAGING
REAGENTS MARKET, BY ASSAY TYPE, THROUGH 2013 ($ MILLIONS)
- TABLE 85 GLOBAL VALUE OF CELLULAR ANALYSIS IN-VITRO OPTICAL FLUORESCENT
IMAGING REAGENTS MARKET, BY ASSAY TYPE, THROUGH 2013 ($ MILLIONS)
- TABLE 86 GLOBAL VALUE OF OPTICAL FLUORESCENT IMAGING REAGENTS, BY END
USE, THROUGH 2013 ($ MILLIONS)
- OPTICAL IMAGING REAGENTS (Continued)
- TABLE 87 GLOBAL VALUE OF IN-VITRO DIAGNOSTIC FLUORESCENT OPTICAL IMAGING
REAGENTS, BY MARKET SEGMENT, THROUGH 2013 ($ MILLIONS)
- TABLE 88 GLOBAL VALUE OF OPTICAL IMAGING REAGENTS, BY TYPE, THROUGH 2013
($ MILLIONS)
- GEOGRAPHICAL
- TABLE 89 GLOBAL VALUE OF BIOLOGIC IMAGING REAGENTS, BY GEOGRAPHY,
THROUGH 2013 ($ MILLIONS)
- Geographical (Continued)
CHAPTER EIGHT: PATENT STATUS
- IMAGING REAGENTS PATENTS BY SELECTED TECHNOLOGY
- TABLE 90 NUMBER OF PATENTS BY TECHNOLOGY
- FLUORESCENCE REAGENTS
- TABLE 91 FLUORESCENCE REAGENTS PATENT ASSIGNEES BY COMPANY (NUMBER OF
PATENTS)
- FLUORESCENT PROTEINS
- TABLE 92 FLUORESCENT PROTEIN PATENT ASSIGNEES BY COMPANY (NUMBER OF
PATENTS)
- DENDRIMERS
- TABLE 93 DENDRIMER PATENT ASSIGNEES BY COMPANY (NUMBER OF PATENTS)
- TABLE 94 QUANTUM DOTS PATENT ASSIGNEES BY COMPANY (NUMBER OF PATENTS)
- PATENTS BY COMPANY
- FIGURE 8 PATENTS BY COMPANY FOR MARKET SEGMENTS
- LITIGATION STATUS
- TABLE 95 IP LITIGATION STATUS
CHAPTER NINE: COMPANY PROFILES
- ACUSPHERE, INC.
- TABLE 96 ACUSPHERE PRODUCT PIPELINE
- TABLE 97 ACUSPHERE PATENT ESTATE
- TABLE 97 (CONTINUED)
- ADVANCED RESEARCH TECHNOLOGIES INC.
- AFFIBODY AB
- AION DIAGNOSTICS
- ALNIS BIOSCIENCES INC.
- ALSERES PHARMACEUTICALS INC.
- AMAG PHARMACEUTICALS
- TABLE 98 AMAG MOLECULAR IMAGING REAGENTS PIPELINE
- TABLE 99 AMAG MRI IMAGING REAGENTS MARKETING ALLIANCES
- ANTICANCER INC
- AVID RADIOPHARMACEUTICALS
- TABLE 100 AVID DIAGNOSTIC IMAGING PIPELINE
- BAYER SCHERING PHARMA AG
- BBI INTERNATIONAL
- BD BIOSCIENCES
- BECKMAN COULTER, INC.
- BIOFORCE NANOSCIENCES HOLDINGS, INC.
- BIOMODA INC.
- BIOPHAN TECHNOLOGIES, INC.
- BIOSEARCH TECHNOLOGIES, INC.
- BIOSCEPTRE
- BIOTAGE AB
- BRACCO DIAGNOSTICS INC
- CALIPER LIFE SCIENCES, INC.
- CAMBRIDGE ISOTOPE LABORATORIES, INC.
- CAPSULUTION NANOSCIENCES AG
- CARDINAL HEALTH
- CARESTREAM HEALTH, INC
- CELLCYTE GENETICS
- CHEMICELL GMBH
- CHINA MEDICAL TECHNOLOGIES, INC.
- COVIDIEN
- DENDRITECH, INC.
- DO-COOP TECHNOLOGIES
- EBIOSCIENCE, INC.
- EPIX PHARMACEUTICALS
- EPIX Pharmaceuticals (Continued)
- EVIDENT TECHNOLOGIES
- EVROGEN
- FERROPHARM GMBH
- FLUOROPHARMA
- TABLE 101 FLUORPHARMA PET IMAGING REAGENT PIPELINE
- FLUOROTECHNICS PTY LTD.
- Fluorotechnics Pty Ltd (Continued)
- GE HEALTHCARE
- TABLE 102 GE HEALTHCARE IMAGING REAGENTS PIPELINE
- GUERBET
- IBA MOLECULAR
- IMMUNICON
- INDEC BIOSYSTEMS
- INVITROGEN
- Invitrogen (Continued)
- JUBILANT ORGANOSYS LTD
- TABLE 103 JUBILANT ORGANOSYS MEDICAL IMAGING REAGENT PIPELINE
- Jubilant Organosys Ltd (Continued)
- KEREOS, INC.
- TABLE 104 KEREOS IMAGING REAGENTS PIPELINE
- TABLE 105 KEREOS STRATEGIC ALLIANCES
- KPL, INC.
- LANTHEUS MEDICAL IMAGING
- TABLE 106 LANTHEUS DIAGNOSTIC IMAGING PIPELINE
- LUNA NANOWORKS
- MARINPHARM GMBH
- MBL INTERNATIONAL
- MOLECULAR INSIGHT PHARMACEUTICALS
- MOLECULAR TARGETING TECHNOLOGIES, INC
- TABLE 107 MTTI IMAGING REAGENTS PIPELINE
- NANOCO TECHNOLOGIES LTD.
- NANOPROBES, INC.
- NANOSPECTRA BIOSCIENCES
- NANOSPHERE, INC.
- TABLE 108 NANOSPHERE GOLD IMAGING REAGENTS PIPELINE
- OXONICA INC.
- PHILIPS HEALTHCARE
- PROMEGA CORPORATION
- SELAH TECHNOLOGIES, LLC
- SIEMENS AG
- Siemens AG (Continued)
- SIGNALOMICS GMBH
- STARPHARMA HOLDINGS LTD
- Starpharma Holdings Ltd (Continued)
- TAKARA BIO INC.
- THERMO FISHER SCIENTIFIC
- TK SIGNAL
- VISEN MEDICAL INC.
- WILEX AG
- TABLE 109 WILEX PRODUCT PIPELINE
LIST OF TABLES
- SUMMARY TABLE GLOBAL VALUE OF BIOLOGIC IMAGING REAGENTS, BY TYPE, THROUGH
2013 ($ MILLIONS)
- TABLE 1 SCOPE OF THIS REPORT
- TABLE 2 GLOBAL VALUE OF BIOLOGIC IMAGING REAGENTS, BY TECHNOLOGY, THROUGH
2013 ($ MILLIONS)
- TABLE 3 GLOBAL VALUE OF BIOLOGIC IMAGING REAGENTS, BY END USER MARKET,
THROUGH 2013 ($ MILLIONS)
- TABLE 4 BIOLOGIC IMAGING REAGENTS GROWTH DRIVING FORCES
- TABLE 5 LIFE CYCLE STAGE OF BIOLOGIC IMAGING REAGENTS
- TABLE 6 BIOLOGIC IMAGING REAGENTS KEY COMPETITORS
- TABLE 7 KEY BIOLOGIC IMAGING REAGENT TYPES
- TABLE 8 IN-VIVO IMAGING MODALITIES
- TABLE 9 COMPARISON OF IN-VIVO IMAGING MODALITIES
- TABLE 10 APPLICATIONS OF IN-VITRO BIOLOGIC IMAGING
- TABLE 11 KEY TRENDS FOR IN-VIVO IMAGING
- TABLE 12 NANOPARTICLES IN IMAGING APPLICATIONS
- TABLE 13 COMPARISON OF ANTIBODY CONJUGATE NANOPARTICLES
- TABLE 14 FLUORESCENT DYES AND PROBES
- TABLE 15 ADVANTAGES OF FLUORESCENCE VERSUS TRADITIONAL METHODS
- TABLE 16 FLUORESCENT DYE PERFORMANCE CRITERIA
- TABLE 17 TYPES OF FLUORESCENT PROTEINS
- TABLE 18 PHOTOACTIVABLE AND PHOTOCONVERTIBLE FLUORESCENT PROTEIN TYPES
- TABLE 19 EMERGING APPLICATIONS OF FLUORESCENT PROTEINS
- TABLE 20 FLUORESCENT PROTEINS VERSUS DYES
- TABLE 21 TECHNOLOGY CHALLENGES FOR FLUORESCENT PROTEINS
- TABLE 22 CLASSIFICATION OF IMAGING SUPERMOLECULES
- TABLE 23 COMPARISON OF QUANTUM DOTS, FLUORESCENT DYES AND FLUORESCENT
PROTEINS
- TABLE 24 BIOLOGIC IMAGING APPLICATIONS OF QUANTUM DOTS
- TABLE 25 EMERGING ADVANCED BIOLOGIC IMAGING REAGENT FUNCTIONS
- TABLE 26 LIFE CYCLE OF BIOLOGIC IMAGING REAGENT TECHNOLOGIES
- TABLE 27 TECHNOLOGY STATUS OF BIOLOGIC IMAGING REAGENT PLATFORMS
- TABLE 28 TECHNOLOGY CHALLENGES FOR IN-VIVO IMAGING REAGENTS
- TABLE 29 BIOLOGIC IMAGING REAGENTS APPLICATIONS
- TABLE 30 SIGNIFICANCE OF BIOLOGIC IMAGING REAGENTS TO LIFE SCIENCES AND
MEDICAL INDUSTRIES
- TABLE 31 USE OF BIOLOGIC IMAGING REAGENTS BY MARKET SEGMENT
- TABLE 32 APPLICATIONS WITHIN MARKET SEGMENTS
- TABLE 33 R&D TOOLS
- TABLE 34 EMERGING APPLICATIONS FOR BIOLOGIC IMAGING REAGENTS IN R&D TOOLS
- TABLE 35 DRUG DISCOVERY & DEVELOPMENT
- TABLE 36 COMPARISON OF SMALL ANIMAL IMAGING MODALITIES
- TABLE 37 OUTSTANDING MARKET NEEDS FOR SMALL ANIMAL IMAGING
- TABLE 38 BIOMARKERS FOR MICRODOSING
- TABLE 39 MICRODOSING IMAGING MODALITIES
- TABLE 40 DIAGNOSTICS IMAGING REAGENTS APPLICATIONS
- TABLE 41 DIAGNOSTIC APPLICATIONS OF SELECTED IMAGING REAGENTS
- TABLE 42 CLINICAL APPLICATIONS FOR IN VIVO MOLECULAR IMAGING
- TABLE 43 FLUORESCENCE IMAGING REAGENTS PIPELINE STATUS
- TABLE 44 PET/SPECT IMAGING REAGENTS PIPELINE STATUS
- TABLE 45 PET IMAGING REAGENT APPLICATIONS
- TABLE 46 EXISTING AND EMERGING MRI IMAGING REAGENTS STATUS
- TABLE 47 NANOPARTICLE IN-VIVO DIAGNOSTICS PIPELINE
- TABLE 48 NANOSPHERE IN-VITRO DIAGNOSTICS REAGENTS PIPELINE
- TABLE 49 HYBRID IMAGING/THERAPEUTIC APPLICATIONS
- TABLE 50 COMPETITIVE FOCUS OF MAJOR MEDICAL IMAGING COMPANIES
- TABLE 51 RECENT IMAGING REAGENT STRATEGIC ALLIANCES
- TABLE 52 BIOLOGIC IMAGING REAGENTS INDUSTRY ACQUISITIONS, 2005-2008
- TABLE 53 FLUORESCENT DYES AND PROBES KEY COMPETITORS
- TABLE 54 QUANTUM DOTS KEY COMPETITORS
- TABLE 55 CONTRAST REAGENTS KEY COMPETITORS
- TABLE 56 RADIOPHARMACEUTICALS BIOTECHNOLOGY COMPANIES
- TABLE 57 SMALL ANIMAL IN-VIVO FUNCTIONAL IMAGING COMPETITORS
- TABLE 58 CARDIAC IMAGING REAGENT COMPETITIVE SPACE
- TABLE 59 FLUORESCENT PROTEIN PRODUCERS
- TABLE 60 ANTIBODY BIOTECHNOLOGY COMPANIES WHO HAVE INTEREST IN IMAGING
REAGENTS
- TABLE 61 BIOLOGIC IMAGING REAGENTS GROWTH DRIVING FORCES
- TABLE 62 GLOBAL VALUE OF INSTRUMENTS AND ASSAYS UTILIZING BIOLOGIC IMAGING
REAGENTS, THROUGH 2013 ($ MILLIONS)
- TABLE 63 GLOBAL VALUE OF BIOLOGIC IMAGING REAGENTS, BY TECHNOLOGY, THROUGH
2013 ($ MILLIONS)
- TABLE 64 GLOBAL VALUE OF BIOLOGIC IMAGING REAGENTS MARKET, BY END USE,
THROUGH 2013 ($ MILLIONS)
- TABLE 65 GLOBAL VALUE OF BIOLOGIC REAGENTS MARKET, BY FUNCTION, THROUGH
2013 ($ MILLIONS)
- TABLE 66 GLOBAL VALUE OF BIOLOGIC IMAGING REAGENTS, BY END USER MARKET,
THROUGH 2013 ($ MILLIONS)
- TABLE 67 GLOBAL VALUE OF BIOLOGIC REAGENTS MARKET, BY MODALITY, THROUGH
2013 ($ MILLIONS)
- TABLE 68 GLOBAL VALUE OF FLUORESCENT PROTEIN REAGENTS, BY TYPE, THROUGH
2013 ($ MILLIONS)
- TABLE 69 GLOBAL VALUE OF IMAGING NANOPARTICLES BY TECHNOLOGY THROUGH 2013
($ MILLIONS)
- TABLE 70 GLOBAL VALUE OF CONTRAST AGENTS MARKET, BY MODALITY, THROUGH 2013
($ MILLIONS)
- TABLE 71 GLOBAL VALUE OF MRI REAGENTS MARKET, BY TYPE, THROUGH 2013 ($
MILLIONS)
- TABLE 72 GLOBAL VALUE OF MRI GD CHELATE REAGENTS, BY PRODUCT, THROUGH 2013
($ MILLIONS)
- TABLE 73 GLOBAL VALUE OF MRI NON-GD CHELATE REAGENTS, BY PRODUCT, THROUGH
2013 ($ MILLIONS)
- TABLE 74 GLOBAL SALES OF MRI CONTRAST REAGENTS, BY PROCEDURE, THROUGH 2013
($ MILLIONS)
- TABLE 75 GLOBAL VALUE OF ULTRASOUND REAGENTS MARKET, BY TYPE, THROUGH 2013
($ MILLIONS)
- TABLE 76 GLOBAL VALUE OF X-RAY/CT REAGENTS MARKET, BY TYPE, THROUGH 2013
($ MILLIONS)
- TABLE 77 GLOBAL VALUE OF RADIOPHARMACEUTICALS IMAGING REAGENTS MARKET, BY
INDICATION, THROUGH 2013 ($ MILLIONS)
- TABLE 78 GLOBAL VALUE OF ONCOLOGY RADIOPHARMACEUTICALS IMAGING REAGENTS
MARKET, BY INDICATION, THROUGH 2013 ($ MILLIONS)
- TABLE 79 GLOBAL VALUE OF ONCOLOGY RADIOPHARMACEUTICALS IMAGING REAGENTS
MARKET, BY PRODUCT, THROUGH 2013 ($ MILLIONS)
- TABLE 80 GLOBAL VALUE OF FDG RADIOPHARMACEUTICAL REAGENTS, BY DISEASE
CLASS, THROUGH 2013 ($ MILLIONS)
- TABLE 81 GLOBAL VALUE OF OPTICAL FLUORESCENT IMAGING REAGENTS MARKET, BY
APPLICATION, THROUGH 2013 ($ MILLIONS)
- TABLE 82 GLOBAL VALUE OF IN-VITRO RESEARCH AND DRUG DISCOVERY AND
DEVELOPMENT OPTICAL FLUORESCENT IMAGING REAGENTS MARKET, BY ASSAY, THROUGH
2013 ($ MILLIONS)
- TABLE 83 GLOBAL VALUE OF GENOMICS IN-VITRO OPTICAL FLUORESCENT IMAGING
REAGENTS MARKET, BY ASSAY TYPE, THROUGH 2013 ($ MILLIONS)
- TABLE 84 GLOBAL VALUE OF PROTEOMICS IN-VITRO OPTICAL FLUORESCENT IMAGING
REAGENTS MARKET, BY ASSAY TYPE, THROUGH 2013 ($ MILLIONS)
- TABLE 85 GLOBAL VALUE OF CELLULAR ANALYSIS IN-VITRO OPTICAL FLUORESCENT
IMAGING REAGENTS MARKET, BY ASSAY TYPE, THROUGH 2013 ($ MILLIONS)
- TABLE 86 GLOBAL VALUE OF OPTICAL FLUORESCENT IMAGING REAGENTS, BY END USE,
THROUGH 2013 ($ MILLIONS)
- TABLE 87 GLOBAL VALUE OF IN-VITRO DIAGNOSTIC FLUORESCENT OPTICAL IMAGING
REAGENTS, BY MARKET SEGMENT, THROUGH 2013 ($ MILLIONS)
- TABLE 88 GLOBAL VALUE OF OPTICAL IMAGING REAGENTS, BY TYPE, THROUGH 2013
($ MILLIONS)
- TABLE 89 GLOBAL VALUE OF BIOLOGIC IMAGING REAGENTS, BY GEOGRAPHY, THROUGH
2013 ($ MILLIONS)
- TABLE 90 NUMBER OF PATENTS BY TECHNOLOGY
- TABLE 91 FLUORESCENCE REAGENTS PATENT ASSIGNEES BY COMPANY (NUMBER OF
PATENTS)
- TABLE 92 FLUORESCENT PROTEIN PATENT ASSIGNEES BY COMPANY (NUMBER OF
PATENTS)
- TABLE 93 DENDRIMER PATENT ASSIGNEES BY COMPANY (NUMBER OF PATENTS)
- TABLE 94 QUANTUM DOTS PATENT ASSIGNEES BY COMPANY (NUMBER OF PATENTS)
- TABLE 95 IP LITIGATION STATUS
- TABLE 96 ACUSPHERE PRODUCT PIPELINE
- TABLE 97 ACUSPHERE PATENT ESTATE
- TABLE 98 AMAG MOLECULAR IMAGING REAGENTS PIPELINE
- TABLE 99 AMAG MRI IMAGING REAGENTS MARKETING ALLIANCES
- TABLE 100 AVID DIAGNOSTIC IMAGING PIPELINE
- TABLE 101 FLUORPHARMA PET IMAGING REAGENT PIPELINE
- TABLE 102 GE HEALTHCARE IMAGING REAGENTS PIPELINE
- TABLE 103 JUBILANT ORGANOSYS MEDICAL IMAGING REAGENT PIPELINE
- TABLE 104 KEREOS IMAGING REAGENTS PIPELINE
- TABLE 105 KEREOS STRATEGIC ALLIANCES
- TABLE 106 LANTHEUS DIAGNOSTIC IMAGING PIPELINE
- TABLE 107 MTTI IMAGING REAGENTS PIPELINE
- TABLE 108 NANOSPHERE GOLD IMAGING REAGENTS PIPELINE
- TABLE 109 WILEX PRODUCT PIPELINE
LIST OF FIGURES
- SUMMARY FIGURE GLOBAL VALUE OF BIOLOGIC IMAGING REAGENTS, BY TYPE,
2006-2013 ($ MILLIONS)
- FIGURE 1 MOLECULAR ENGINEERING OF DENDRIMER IMAGING SUPERMOLECULES
- FIGURE 2 QUANTUM DOT SPECTRA
- FIGURE 3 FLUORESCENT DYE SPECTRA
- FIGURE 4 THREE COMPONENTS OF ADVANCED IMAGING REAGENT TECHNOLOGY
- FIGURE 5 MANUFACTURING COSTS OF IMAGING REAGENT CLASSES
- FIGURE 6 ATTRITION RATE OF DRUG CANDIDATES DURING DRUG DEVELOPMENT
- FIGURE 7 ALZHEIMER' S DISEASE' S PATHOLOGY PROGRESSION
- FIGURE 8 PATENTS BY COMPANY FOR MARKET SEGMENTS
|
Related Report
|
View Cart
